Clinically Validated Mobile-Based Digital Psychotherapy For Stress and Mental Wellbeing
Mental health has become one of the biggest risk factors in accelerating illness and accounting for the largest component in occupational health claims. Managing mental health-related issues often require individuals’ conscientious efforts to seek suitable treatment regime including psychotherapy, which may be dependent on the availability of therapists or mental health practitioners. This calls for alternative solutions that can support individuals for managing their mental wellbeing, thereby improving their quality of life.
Digital therapeutics (DTx) are evidence-based therapeutic interventions for the prevention, management or treatment of medical conditions or diseases, including mental health-related issues. These include digital self-management implementations in formats such as mobile apps, sensors, virtual reality, or other tools to prompt behavioral changes in users.
Aiming as a transformative DTx to improve health and reduce healthcare-associated costs, the current technology is a clinically proven digital mobile-based psychotherapy tool that collectively measures certain physiological parameters as an objective digital biomarker of stress. With its implementation in smartphones and mobile apps, this provides ease of accessibility to individuals for his/her objective stress assessment. The technology is currently a CE Class I Medical Device and is approved with GDPR, HIPPA, PHIPA, ISO 13485, ISO 9000 and ISO 27001. The Singapore-based technology owner has completed three clinical trials in use cases including cancer, anxiety and athletic endurance.
The technology owner is seeking potential licensees, including players in telemedicine sector, pharmaceutical companies or insurance companies who may have interests to license their stress digital biomarkers via API/white label, and/or the associated proprietary technology.